Jaguar Health (JAGX) Short term Debt (2014 - 2017)
Jaguar Health (JAGX) posted quarterly Short term Debt of $1.6 million for Q4 2017, down 16.17% year-over-year from $1.9 million in Q4 2016, and down 10.66% quarter-over-quarter from $1.8 million in Q3 2017.
Jaguar Health (JAGX) Short term Debt (2014 - 2017) Analysis & Trends
Jaguar Health (JAGX) has reported Short term Debt for 4 consecutive years, with $1.6 million the latest figure, recorded in Q4 2017.
- In Q4 2017, Short term Debt fell 16.17% year-over-year to $1.6 million; the TTM figure through Dec 2017 stood at $1.6 million (down 16.17% YoY), while the FY2017 annual figure was $1.6 million, down 16.17% from the prior year.
- Short term Debt eased to $1.6 million in Q4 2017 per JAGX's latest filing, from $1.8 million in the prior quarter.
- Across five years, Short term Debt topped out at $2.1 million in Q1 2016 and bottomed at $16581.0 in Q4 2014.
- Historically, Short term Debt has averaged $1.5 million across 4 years, with a median of $1.8 million in 2015.
- Annual changes were most pronounced in 2015 — Short term Debt soared 10200.34% — and 2017, when it fell 16.17%.
- Jaguar Health's Short term Debt stood at $16581.0 in 2014, then jumped by 10200.34% to $1.7 million in 2015, then rose by 12.4% to $1.9 million in 2016, then decreased by 16.17% to $1.6 million in 2017.
- Business Quant data shows JAGX's Short term Debt at $1.6 million in Q4 2017, $1.8 million in Q3 2017, and $2.1 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Jaguar Health | 442,494.54 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.61 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 2.07 Mn |
| Mar 31, 2017 | 1.99 Mn |
| Dec 31, 2016 | 1.92 Mn |
| Sep 30, 2016 | 1.85 Mn |
| Jun 30, 2016 | 1.47 Mn |
| Mar 31, 2016 | 2.12 Mn |
| Dec 31, 2015 | 1.71 Mn |
| Sep 30, 2015 | 1.45 Mn |
| Mar 31, 2015 | 21,244.00 |
| Dec 31, 2014 | 16,581.00 |